Silco Pharmaceuticals Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	31.9	26.26	28.7	30.76	26.72	53.03
Short-Term Investments	-	-	1.77	18.97	37.91	19.41
Cash & Short-Term Investments	31.9	26.26	30.47	49.73	64.63	72.44
Cash Growth	4.69%	-13.82%	-38.73%	-23.04%	-10.79%	-71.91%
Receivables	429.81	412.83	419.59	377.51	389.24	390.53
Inventory	448.06	450.67	444.1	444.14	457.84	449.45
Prepaid Expenses	-	0.59	0.59	-	0.21	0.21
Other Current Assets	128.28	126.95	160.19	133.55	136.83	139.59
Total Current Assets	1,038	1,017	1,055	1,005	1,049	1,052
Property, Plant & Equipment	1,742	1,743	1,767	1,762	1,671	1,643
Other Long-Term Assets	0	0	-	-0	-0	0
Total Assets	2,781	2,761	2,822	2,767	2,720	2,696
Accounts Payable	9.03	9.52	9.6	9.75	12.33	16.15
Accrued Expenses	10.91	10.48	9.18	9.27	16.93	21.21
Current Portion of Leases	3.78	4.99	4.26	-	4.11	3.77
Current Income Taxes Payable	193.51	188.97	285.19	273.7	255.21	240.41
Other Current Liabilities	2.16	2.17	2.56	3.04	2.33	1.42
Total Current Liabilities	219.39	216.13	310.8	295.76	290.91	282.96
Long-Term Leases	-	-	5.31	-	-	4.11
Long-Term Deferred Tax Liabilities	154.9	154.71	153.71	151.73	150.21	140.5
Other Long-Term Liabilities	0	-0	0	-0	-	0
Total Liabilities	374.29	370.84	469.82	447.5	441.11	427.57
Common Stock	1,038	1,038	1,038	1,038	1,038	1,038
Retained Earnings	1,368	1,352	1,316	1,289	1,251	1,230
Comprehensive Income & Other	-	-	-1.15	-6.92	-10.69	-0.37
Shareholders' Equity	2,406	2,390	2,352	2,320	2,279	2,268
Total Liabilities & Equity	2,781	2,761	2,822	2,767	2,720	2,696
Total Debt	3.78	4.99	9.57	-	4.11	7.89
Net Cash (Debt)	28.12	21.27	20.9	49.73	60.51	64.56
Net Cash Growth	34.52%	1.76%	-57.97%	-17.82%	-6.26%	-74.97%
Net Cash Per Share	0.27	0.20	0.20	0.48	0.58	0.62
Filing Date Shares Outstanding	103.81	103.81	103.81	103.81	103.81	103.81
Total Common Shares Outstanding	103.81	103.81	103.81	103.81	103.81	103.81
Working Capital	818.66	801.16	744.14	709.17	757.83	769.27
Book Value Per Share	23.18	23.02	22.66	22.35	21.95	21.85
Tangible Book Value	2,406	2,390	2,352	2,320	2,279	2,268
Tangible Book Value Per Share	23.18	23.02	22.66	22.35	21.95	21.85
Land	-	74.85	74.85	74.85	74.85	74.85
Buildings	-	1,111	1,083	1,004	880.25	700.05
Machinery	-	1,609	1,576	1,524	1,443	1,320
Construction In Progress	-	137.32	128.1	174.96	197.38	394.59

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.